{"id":55877,"date":"2023-04-17T13:04:18","date_gmt":"2023-04-17T11:04:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/"},"modified":"2023-04-17T13:04:18","modified_gmt":"2023-04-17T11:04:18","slug":"bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/","title":{"rendered":"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3"},"content":{"rendered":"<div>\n<p>VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211;Bausch + Lomb Corporation (NYSE\/TSX: BLCO) (\u201cBausch + Lomb\u201d), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2023 financial results on Wednesday, May 3, 2023. Bausch + Lomb will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230417005065\/en\/1668940\/5\/Bausch_%2B_Lomb_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230417005065\/en\/1668940\/21\/Bausch_%2B_Lomb_logo.jpg\"><\/a><\/p>\n<p>\n<b>Conference Call Details<\/b><\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nDate:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWednesday, May 3, 2023<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTime:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n8:00 a.m. ET<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWebcast:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.webcaster4.com%2FWebcast%2FPage%2F2883%2F47444&amp;esheet=53381148&amp;newsitemid=20230417005065&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.webcaster4.com%2FWebcast%2FPage%2F2883%2F47444&amp;index=1&amp;md5=23274fcbb7047adb5db0e2a5d763bc0d\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.webcaster4.com\/Webcast\/Page\/2883\/47444<\/a><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nParticipant Event Dial-in:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n+1 (888) 506-0062 (North America)<\/p>\n<p class=\"bwcellpmargin\">\n+1 (973) 528-0011 (International)<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nParticipant Access Code:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n937525<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nReplay Dial-in:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n+1 (877) 481-4010 (North America)<\/p>\n<p class=\"bwcellpmargin\">\n+1 (919) 882-2331 (International)<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nReplay Passcode:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n47444 (replay available until May 17, 2023)<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n<b>About Bausch + Lomb<\/b><\/p>\n<p>\nBausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world \u2013 from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bausch.com&amp;esheet=53381148&amp;newsitemid=20230417005065&amp;lan=en-US&amp;anchor=www.bausch.com&amp;index=2&amp;md5=cd85fac6cb87b4a5f1d80c7413c05327\" rel=\"nofollow noopener\" shape=\"rect\">www.bausch.com<\/a> and connect with us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FBauschLomb&amp;esheet=53381148&amp;newsitemid=20230417005065&amp;lan=en-US&amp;anchor=Twitter&amp;index=3&amp;md5=d1936103a7543a92b10e31ee1b7ad401\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F5185%2Fadmin%2F&amp;esheet=53381148&amp;newsitemid=20230417005065&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=b775866b7a20c9929ead78ee45a9abd2\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FBauschandLomb&amp;esheet=53381148&amp;newsitemid=20230417005065&amp;lan=en-US&amp;anchor=Facebook&amp;index=5&amp;md5=23c2fbce96548d160a811b422d1f0156\" rel=\"nofollow noopener\" shape=\"rect\">Facebook<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fbauschlomb%2F%3Fhl%3Den&amp;esheet=53381148&amp;newsitemid=20230417005065&amp;lan=en-US&amp;anchor=Instagram&amp;index=6&amp;md5=6de988f3572973c93a30423bf6569073\" rel=\"nofollow noopener\" shape=\"rect\">Instagram<\/a>.<\/p>\n<p>\n<i>\u00a9 2023 Bausch &amp; Lomb Incorporated or its affiliates.<\/i><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contacts:<\/b><br \/>Arthur Shannon<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x41;r&#116;&#x68;&#x75;r&#46;&#x73;&#x68;a&#110;&#x6e;&#x6f;n&#64;&#98;&#x61;&#x75;s&#99;&#x68;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">Ar&#116;&#104;&#117;&#x72;&#x2e;&#x73;&#x68;&#x61;nn&#111;&#110;&#64;&#x62;&#x61;&#x75;&#x73;&#x63;h&#46;&#99;&#111;&#109;<\/a><\/p>\n<p>\nAllison Ryan<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x61;&#108;&#x6c;&#105;&#x73;&#111;&#x6e;&#46;&#x72;&#121;&#x61;&#110;&#x40;&#98;&#x61;&#117;&#x73;&#99;&#x68;&#104;&#x65;&#97;&#x6c;&#116;&#x68;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x61;&#108;&#108;i&#x73;&#x6f;&#110;&#46;&#x72;&#x79;&#97;n&#64;&#x62;&#97;&#117;s&#x63;&#x68;&#46;c&#x6f;&#x6d;<\/a><br \/>(877) 354-3705 (toll free)<br \/>\n<br \/>(908) 927-0735<\/p>\n<p>\n<b>Media Contacts:<\/b><br \/>Lainie Keller<br \/>\n<br \/><a target=\"_blank\" href=\"mailto&#58;&#108;&#97;&#105;&#110;&#105;&#101;&#x2e;&#x6b;&#x65;&#x6c;&#x6c;&#x65;&#x72;&#x40;&#x62;&#x61;&#x75;&#x73;ch&#46;com\" rel=\"nofollow noopener\" shape=\"rect\">l&#97;&#x69;&#x6e;i&#101;&#46;&#x6b;&#x65;l&#108;&#x65;&#x72;&#64;&#98;&#97;&#x75;&#x73;c&#104;&#x2e;&#x63;o&#109;<\/a><br \/>(908) 927-1198<\/p>\n<p>\nKristy Marks<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#x74;&#111;:&#x6b;&#x72;&#105;s&#x74;&#121;&#46;&#x6d;&#x61;&#114;k&#x73;&#x40;&#98;a&#x75;&#115;&#99;&#x68;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;&#114;&#105;s&#x74;&#x79;&#46;m&#x61;&#x72;&#107;s&#64;&#x62;&#97;&#117;s&#x63;&#x68;&#46;c&#x6f;&#x6d;<\/a><br \/>(908) 927-0683<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211;Bausch + Lomb Corporation (NYSE\/TSX: BLCO) (\u201cBausch + Lomb\u201d), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2023 financial results on Wednesday, May 3, 2023. Bausch + Lomb will host a conference call and live web cast at 8:00 a.m. ET to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55877","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211;Bausch + Lomb Corporation (NYSE\/TSX: BLCO) (\u201cBausch + Lomb\u201d), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2023 financial results on Wednesday, May 3, 2023. Bausch + Lomb will host a conference call and live web cast at 8:00 a.m. ET to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-17T11:04:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230417005065\/en\/1668940\/21\/Bausch_%2B_Lomb_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3\",\"datePublished\":\"2023-04-17T11:04:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/\"},\"wordCount\":288,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230417005065\\\/en\\\/1668940\\\/21\\\/Bausch_%2B_Lomb_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/\",\"name\":\"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230417005065\\\/en\\\/1668940\\\/21\\\/Bausch_%2B_Lomb_logo.jpg\",\"datePublished\":\"2023-04-17T11:04:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230417005065\\\/en\\\/1668940\\\/21\\\/Bausch_%2B_Lomb_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230417005065\\\/en\\\/1668940\\\/21\\\/Bausch_%2B_Lomb_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/","og_locale":"en_US","og_type":"article","og_title":"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3 - Pharma Trend","og_description":"VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211;Bausch + Lomb Corporation (NYSE\/TSX: BLCO) (\u201cBausch + Lomb\u201d), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2023 financial results on Wednesday, May 3, 2023. Bausch + Lomb will host a conference call and live web cast at 8:00 a.m. ET to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-17T11:04:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230417005065\/en\/1668940\/21\/Bausch_%2B_Lomb_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3","datePublished":"2023-04-17T11:04:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/"},"wordCount":288,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230417005065\/en\/1668940\/21\/Bausch_%2B_Lomb_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/","url":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/","name":"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230417005065\/en\/1668940\/21\/Bausch_%2B_Lomb_logo.jpg","datePublished":"2023-04-17T11:04:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230417005065\/en\/1668940\/21\/Bausch_%2B_Lomb_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230417005065\/en\/1668940\/21\/Bausch_%2B_Lomb_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2023-financial-results-on-may-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55877"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55877\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}